156 related articles for article (PubMed ID: 18404377)
1. Filamin A mutant lacking actin-binding domain restores mu opioid receptor regulation in melanoma cells.
Onoprishvili I; Ali S; Andria ML; Shpigel A; Simon EJ
Neurochem Res; 2008 Oct; 33(10):2054-61. PubMed ID: 18404377
[TBL] [Abstract][Full Text] [Related]
2. Chronic morphine treatment up-regulates mu opioid receptor binding in cells lacking filamin A.
Onoprishvili I; Simon EJ
Brain Res; 2007 Oct; 1177():9-18. PubMed ID: 17897634
[TBL] [Abstract][Full Text] [Related]
3. The interaction between the mu opioid receptor and filamin A.
Simon EJ; Onoprishvili I
Neurochem Res; 2010 Dec; 35(12):1859-66. PubMed ID: 20857334
[TBL] [Abstract][Full Text] [Related]
4. Interaction between the mu opioid receptor and filamin A is involved in receptor regulation and trafficking.
Onoprishvili I; Andria ML; Kramer HK; Ancevska-Taneva N; Hiller JM; Simon EJ
Mol Pharmacol; 2003 Nov; 64(5):1092-100. PubMed ID: 14573758
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy.
Duff RM; Tay V; Hackman P; Ravenscroft G; McLean C; Kennedy P; Steinbach A; Schöffler W; van der Ven PFM; Fürst DO; Song J; Djinović-Carugo K; Penttilä S; Raheem O; Reardon K; Malandrini A; Gambelli S; Villanova M; Nowak KJ; Williams DR; Landers JE; Brown RH; Udd B; Laing NG
Am J Hum Genet; 2011 Jun; 88(6):729-740. PubMed ID: 21620354
[TBL] [Abstract][Full Text] [Related]
6. Disease-associated substitutions in the filamin B actin binding domain confer enhanced actin binding affinity in the absence of major structural disturbance: Insights from the crystal structures of filamin B actin binding domains.
Sawyer GM; Clark AR; Robertson SP; Sutherland-Smith AJ
J Mol Biol; 2009 Jul; 390(5):1030-47. PubMed ID: 19505475
[TBL] [Abstract][Full Text] [Related]
7. High-affinity naloxone binding to filamin a prevents mu opioid receptor-Gs coupling underlying opioid tolerance and dependence.
Wang HY; Frankfurt M; Burns LH
PLoS One; 2008 Feb; 3(2):e1554. PubMed ID: 18253501
[TBL] [Abstract][Full Text] [Related]
8. Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and beta-arrestins.
Scott MG; Pierotti V; Storez H; Lindberg E; Thuret A; Muntaner O; Labbé-Jullié C; Pitcher JA; Marullo S
Mol Cell Biol; 2006 May; 26(9):3432-45. PubMed ID: 16611986
[TBL] [Abstract][Full Text] [Related]
9. Agonist-induced, G protein-dependent and -independent down-regulation of the mu opioid receptor. The receptor is a direct substrate for protein-tyrosine kinase.
Pak Y; O'Dowd BF; Wang JB; George SR
J Biol Chem; 1999 Sep; 274(39):27610-6. PubMed ID: 10488100
[TBL] [Abstract][Full Text] [Related]
10. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC.
Kramer HK; Simon EJ
J Neurochem; 1999 Feb; 72(2):594-604. PubMed ID: 9930731
[TBL] [Abstract][Full Text] [Related]
11. A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro.
Knapman A; Santiago M; Connor M
Br J Pharmacol; 2015 May; 172(9):2258-72. PubMed ID: 25521224
[TBL] [Abstract][Full Text] [Related]
12. Orphanin FQ/nociceptin potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin-Induced mu-opioid receptor phosphorylation.
Ozsoy HZ; Thakker DR; Standifer KM
Mol Pharmacol; 2005 Aug; 68(2):447-56. PubMed ID: 15890842
[TBL] [Abstract][Full Text] [Related]
13. beta-Arrestin 2-mediated heterologous desensitization of IGF-IR by prolonged exposure of SH-SY5Y neuroblastoma cells to a mu opioid agonist.
Spartà A; Baiula M; Campbell G; Spampinato S
FEBS Lett; 2010 Aug; 584(16):3580-6. PubMed ID: 20643133
[TBL] [Abstract][Full Text] [Related]
14. High affinity interaction with filamin A protects against calcium-sensing receptor degradation.
Zhang M; Breitwieser GE
J Biol Chem; 2005 Mar; 280(12):11140-6. PubMed ID: 15657061
[TBL] [Abstract][Full Text] [Related]
15. Adapter protein SH2B1beta binds filamin A to regulate prolactin-dependent cytoskeletal reorganization and cell motility.
Rider L; Diakonova M
Mol Endocrinol; 2011 Jul; 25(7):1231-43. PubMed ID: 21566085
[TBL] [Abstract][Full Text] [Related]
16. Role of G Protein-Coupled Receptor Kinases 2 and 3 in μ-Opioid Receptor Desensitization and Internalization.
Lowe JD; Sanderson HS; Cooke AE; Ostovar M; Tsisanova E; Withey SL; Chavkin C; Husbands SM; Kelly E; Henderson G; Bailey CP
Mol Pharmacol; 2015 Aug; 88(2):347-56. PubMed ID: 26013542
[TBL] [Abstract][Full Text] [Related]
17. μ-Opioid receptor desensitization: homologous or heterologous?
Llorente J; Lowe JD; Sanderson HS; Tsisanova E; Kelly E; Henderson G; Bailey CP
Eur J Neurosci; 2012 Dec; 36(12):3636-42. PubMed ID: 23002724
[TBL] [Abstract][Full Text] [Related]
18. Interaction of filamin A with the insulin receptor alters insulin-dependent activation of the mitogen-activated protein kinase pathway.
He HJ; Kole S; Kwon YK; Crow MT; Bernier M
J Biol Chem; 2003 Jul; 278(29):27096-104. PubMed ID: 12734206
[TBL] [Abstract][Full Text] [Related]
19. Mu and kappa opioid receptors activate ERK/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes.
Belcheva MM; Clark AL; Haas PD; Serna JS; Hahn JW; Kiss A; Coscia CJ
J Biol Chem; 2005 Jul; 280(30):27662-9. PubMed ID: 15944153
[TBL] [Abstract][Full Text] [Related]
20. Phosphoinositide 3-kinase cascade facilitates mu-opioid desensitization in sensory neurons by altering G-protein-effector interactions.
Tan M; Groszer M; Tan AM; Pandya A; Liu X; Xie CW
J Neurosci; 2003 Nov; 23(32):10292-301. PubMed ID: 14614088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
